The Regulation of PD-L1 Secretion in Extracellular Vesicles by Melanoma Cells
- Weitere Titel
-
Die Regulierung der PD-L1-Sekretion in Extrazellulären Vesikeln durch Melanomzellen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2023
- Schlagwort
-
Krebs
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2023
- Urheber
- Beteiligte Personen und Organisationen
-
Baur, Andreas
Baur, Andreas
Taubert, Helge
- DOI
-
10.25593/open-fau-15
- URN
-
urn:nbn:de:101:1-2023122107160650205210
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Jie
- Baur, Andreas
- Baur, Andreas
- Taubert, Helge
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2023
Ähnliche Objekte (12)
MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma
MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
Potential prognostic value of PD-L1 and NKG2A expression in Indonesian patients with skin nodular melanoma
MIIP downregulates PD-L1 expression through HDAC6 in cutaneous melanoma
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma
IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
IL2‐mediated modulation of small extracellular vesicles secretion and PD‐L1 expression: a novel perspective for neutralizing immune suppression within cancer cells
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects